Would you feel comfortable changing to subcutaneous pertuzumab/trastuzumab in a patient who has already been receiving IV formulation?  

Or the converse:  changing to IV formulation after starting on subcutaneous pertuzumab/trastuzumab?



Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Community Practice

Answer from: Medical Oncologist at Academic Institution